A Randomized Double-Blind Controlled Trial of Mosapride for Patients with Functional Constipation

Xiaohua Hou
2005-01-01
Abstract:Objective To evaluate the theraputic effect on functional constipation.Methods Randomized double-blind control study was applied to observe the defecate frequencies,stool property and constipation symptom grade in 58 patients with functional constipation treated by mosapride and placebo.Gastrointestinal motility function was tested by gastrointestinal transit time before and after treatment.Results Average barium bar left rates are 68% ±7% and 41%±3% (P0.05) before and after mosapride treatment,respectively.Weekly average defecate frequencies were increased from (2.4±0.4)/w to (5.0±0.5)/w(P0.05).stool property scoring was changed from 2.5±0.5 to 5.1±0.1 (P0.05),constipation symptom grades were reduced from 11.25±0.75 to 5.5± 0.22 (P0.05) after mosapride treatment.In placebo group,weekly average defecate frequencies were 2.3±0.1 before treatment and 3.25±0.5 in the second week after treatment (P0.05),correspondingly,stool property scoring is 2.0±0.3 and 2.5±0.5 (P0.05),constipation symptom grades are 10.2±0.55 and 3.35±0.51 (P 0.05).Conclusion Mosapride can decrease barium bar left rates in patients with functional constipation,and it indicates that increase of defecate frequencies may be due to accelerated gastrointestinal motility.
What problem does this paper attempt to address?